Originally published in MedAdNews, June 2025 Introduction As the pharmaceutical indust...
Introduction Since the explosion of Generative AI (GenAI) in 2022, daily breakthroughs in AI featur...
Originally published in Med Ad News December 2024 As an industry, biopharma understands the immense...
Originally published in Med Ad News June 2024 In recent years, biopharma companies have been keen...
Originally published in PharmaLive.com 2/16/24 ChatGPT is the fastest-growing application in hist...
Originally published in Pharmaceutical Commerce 9/29/23 A look into ways to approach change managem...
Gregg Fisher, The Stem's Founder and Managing Partner, recently had the chance to interview both cli...
In the United States, a rare disease is defined as a condition that affects fewer than 200,000 people in the US. In the European Union, a disease is defined as rare when it affects fewer than 1 in 2,000 people.
In this white paper, we describe the value of setting up a Program Management Office (PMO) to manage your omnichannel execution efforts and how to staff it...
The Stem is a global "networked consultancy" specializing in customer engagement and digital transformation.
Navigate the most difficult customer engagement challenges with agility and reliability.
We configure teams of the best minds in customer engagement and digital transformation.
We are always seeking new independent talent to join our team.
The Stem is the leading networked consultancy for Health & Life Sciences innovators seeking to transform their customer experiences.